Benign neoplasms of gynecological system. Rate chronic residuals to include scars, lymphedema, disfigurement, and/or other impairment of function under the appropriate diagnostic code(s) within the appropriate body system — VA Rating Criteria (38 CFR DC 7628)

The VA rates Benign neoplasms of gynecological system. Rate chronic residuals to include scars, lymphedema, disfigurement, and/or other impairment of function under the appropriate diagnostic code(s) within the appropriate body system under Diagnostic Code 7628 at the following tiers: 0%, 10%, 30%. The minimum 0% rating requires: Symptoms that do not require continuous treatment. The maximum 30% rating requires: Symptoms not controlled by continuous treatment.

Diagnostic Code 7628 is the VA rating identifier for Benign neoplasms of gynecological system. Rate chronic residuals to include scars, lymphedema, disfigurement, and/or other impairment of function under the appropriate diagnostic code(s) within the appropriate body system within 38 CFR 38 CFR § 4.116. It defines the specific symptom criteria and percentage thresholds a VA adjudicator uses to assign a disability rating. The diagnostic code is listed on a veteran's rating decision letter.

The highest schedular rating for Benign neoplasms of gynecological system. Rate chronic residuals to include scars, lymphedema, disfigurement, and/or other impairment of function under the appropriate diagnostic code(s) within the appropriate body system under DC 7628 is 30%. This tier requires: Symptoms not controlled by continuous treatment. Veterans who cannot secure substantially gainful employment due to Benign neoplasms of gynecological system. Rate chronic residuals to include scars, lymphedema, disfigurement, and/or other impairment of function under the appropriate diagnostic code(s) within the appropriate body system alone or in combination with other service-connected conditions may also qualify for TDIU at the 100% compensation rate under 38 CFR § 4.16.

Benign neoplasms of gynecological system. Rate chronic residuals to include scars, lymphedema, disfigurement, and/or other impairment of function under the appropriate diagnostic code(s) within the appropriate body system is rated under 38 CFR 38 CFR § 4.116, Diagnostic Code 7628. This section is part of the Schedule for Rating Disabilities (38 CFR Part 4) and can be read in full at the eCFR website.

Secondary conditions caused or aggravated by Benign neoplasms of gynecological system. Rate chronic residuals to include scars, lymphedema, disfigurement, and/or other impairment of function under the appropriate diagnostic code(s) within the appropriate body system may be ratable under 38 CFR § 3.310. Veterans should work with a VSO or accredited claims agent to document the medical relationship.

The key evidence for Benign neoplasms of gynecological system. Rate chronic residuals to include scars, lymphedema, disfigurement, and/or other impairment of function under the appropriate diagnostic code(s) within the appropriate body system depends on the body system. Treatment records showing worsening symptoms, functional limitations documented by your provider, and buddy statements describing observable daily impact all strengthen the claim. A nexus letter from a qualified medical professional is essential for contested claims.

Benign neoplasms of gynecological system. Rate chronic residuals to include scars, lymphedema, disfigurement, and/or other impairment of function under the appropriate diagnostic code(s) within the appropriate body system maxes at 30%, below the single-disability TDIU threshold of 60%. However, combined with other service-connected disabilities totaling 70%+ (with one at 40%+), TDIU under § 4.16(a) may apply. Extraschedular TDIU under § 4.16(b) is available if Benign neoplasms of gynecological system. Rate chronic residuals to include scars, lymphedema, disfigurement, and/or other impairment of function under the appropriate diagnostic code(s) within the appropriate body system alone prevents work regardless of the rating percentage.